Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?

JAMA Psychiatry. 2023 Dec 1;80(12):1187-1188. doi: 10.1001/jamapsychiatry.2023.3979.
No abstract available

Plain language summary

This Viewpoint examines key issues stemming from several recent reports of electroconvulsive therapy (ECT) vs ketamine for improving depressive symptoms in treatment-resistant depression (TRD).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Depression
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Treatment-Resistant* / therapy
  • Electroconvulsive Therapy*
  • Humans
  • Ketamine* / pharmacology
  • Ketamine* / therapeutic use
  • Outpatients
  • Treatment Outcome

Substances

  • Ketamine